Cart
sales@molnova.com
Se-Aspirin
CAS No. 1850293-95-6
Se-Aspirin( —— )
Catalog No. M33763 CAS No. 1850293-95-6
Se-Aspirin (Se-NSAID-8) has anticancer activity and gastroprotective effects, inhibits activation of proinflammatory and pro-survival NF- B pathways, and inhibits the expression of anti-apoptotic targets downstream of NF- B (e.g., Bcl-xL, Mcl-1, and survivin).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 320 | In Stock |
|
| 10MG | 502 | In Stock |
|
| 25MG | 1064 | In Stock |
|
| 50MG | 1730 | In Stock |
|
| 100MG | 2316 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSe-Aspirin
-
NoteResearch use only, not for human use.
-
Brief DescriptionSe-Aspirin (Se-NSAID-8) has anticancer activity and gastroprotective effects, inhibits activation of proinflammatory and pro-survival NF- B pathways, and inhibits the expression of anti-apoptotic targets downstream of NF- B (e.g., Bcl-xL, Mcl-1, and survivin).
-
DescriptionSe-Aspirin (Se-NSAID-8) has anticancer activity and gastroprotective effects, inhibits activation of proinflammatory and pro-survival NF- B pathways, and inhibits the expression of anti-apoptotic targets downstream of NF- B (e.g., Bcl-xL, Mcl-1, and survivin).Se-Aspirin induces Cell cycle arrest and activation of apoptosis accelerates ulcer healing and can be used to study pancreatic and colorectal cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | BCL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1850293-95-6
-
Formula Weight311.2
-
Molecular FormulaC12H12N2O3Se
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#C[Se]CCNC(=O)C=1C=CC=CC1OC(=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Millepachine
Millepachine is a natural product found in the Chinese herbal medicine with strong antitumor effects against numerous human cancer cells.
-
ZDLD20
ZDLD20 is an orally active and selective CDK4 inhibitor, a β-carboline analog with anti-HCT116 and anticancer activity that inhibits colony formation, inhibits invasion and migration, induces apoptosis, and prevents the G1 phase of the cell cycle.
-
Tafasitamab
Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma.
